# DCD

## Overview
The DCD gene encodes dermcidin, a multifunctional protein primarily recognized for its role as an antimicrobial peptide. Dermcidin is secreted by eccrine sweat glands and plays a critical role in the innate immune defense of human skin by forming a protective barrier against microbial invasion. Structurally, dermcidin is characterized by its amphipathic α-helical conformation, which facilitates its interaction with bacterial membranes, leading to the disruption of bacterial cell integrity. Beyond its antimicrobial properties, dermcidin is involved in various cellular processes, including cancer cell migration and signaling pathways, particularly through interactions with proteins such as GRP78 and ERBB family receptors. These interactions suggest a potential role in oncogenic signaling and drug resistance in cancer. The expression of the DCD gene is also implicated in several clinical conditions, including cancer progression and neurodegenerative diseases, highlighting its complex role in human health (Tricarico2022A; Nguyen2017Structural; Lager2021Cell).

## Structure
The dermcidin (DCD) protein is an antimicrobial peptide secreted by human sweat glands. Its primary structure includes a precursor protein that is cleaved into active peptides, with DCD-1L being a notable derivative consisting of the N-terminal 47 residues of DCD plus an additional leucine (Nguyen2017Structural). The secondary structure of DCD-1L is characterized by an amphipathic α-helical conformation, with three well-defined α-helices connected by flexible turns. These helices are formed by residues S2 to L18 (α1), K23 to E30 (α2), and G33 to L47 (α3) (Nguyen2017Structural).

In terms of tertiary structure, DCD-1L adopts an 'L-shaped' conformation in SDS micelles, with the N-terminal region being cationic and amphipathic, while the C-terminal region is anionic (Nguyen2017Structural). The peptide can form oligomeric complexes on bacterial membranes, stabilized by Zn2+, which are essential for its antimicrobial function (Nguyen2017Structural). The quaternary structure involves the formation of a hexameric α-helical bundle in the presence of Zn2+, which coordinates at the H38 residue, facilitating oligomerization and channel formation in bacterial membranes (Nguyen2017Structural). 

DCD-1L's structure is flexible, with the N-terminal half being less restricted and containing several glycines, contributing to its flexibility (Jung2010Analysis). The peptide's amphipathic nature and helical content are crucial for its interaction with bacterial membranes (Jung2010Analysis).

## Function
The DCD gene encodes dermcidin, an antimicrobial peptide that plays a crucial role in the innate immune defense of human skin. Dermcidin is specifically expressed in eccrine sweat glands and is secreted into sweat, where it undergoes proteolytic processing to become active. Once activated, dermcidin is transported to the epidermal surface, where it forms a protective barrier that contributes to the skin's defense against microbial invasion (Tricarico2022A).

The active form of dermcidin consists of 48 amino acids and features an amphiphilic structure with a cationic N-terminal region and an anionic C-terminal region. This structure allows dermcidin to interact with negatively charged bacterial phospholipids, leading to the formation of ion channels in bacterial membranes. This interaction disrupts the structural integrity of bacterial cells, resulting in bacterial cell death (Tricarico2022A).

Dermcidin exhibits significant antimicrobial activity against a range of bacteria, including staphylococcal strains such as S. aureus, S. epidermidis, and S. lugdunensis. It also inhibits biofilm formation by S. aureus, further enhancing its role in maintaining skin health and preventing bacterial overgrowth (Tricarico2022A).

## Clinical Significance
Altered expression of the DCD gene, which encodes the antimicrobial peptide dermcidin, has been implicated in several diseases and conditions. Overexpression of DCD is associated with tumor progression, suggesting a role in cancer development. This overexpression may contribute to the aggressive behavior of certain tumors, although the precise mechanisms remain under investigation. Conversely, reduced levels of dermcidin can impair the skin's defense mechanisms, potentially leading to increased susceptibility to skin infections. This highlights the importance of DCD in maintaining skin integrity and its role in innate immunity.

In addition to its involvement in cancer and skin infections, altered DCD expression has been linked to neurodegenerative diseases. While the exact relationship between DCD and these conditions is not fully understood, it is hypothesized that changes in dermcidin levels may influence disease progression or severity. The dual role of DCD in both promoting tumor growth and protecting against infections underscores its complex involvement in human health and disease. Further research is needed to elucidate the pathways through which DCD contributes to these diverse clinical outcomes.

## Interactions
Dermcidin (DCD) interacts with several proteins, playing a significant role in breast cancer cell migration and signaling pathways. DCD is identified as a novel binding partner for cell surface GRP78 (sGRP78) in both pluripotent stem cells and breast cancer cells. This interaction is crucial for regulating cell migration through the Wnt/β-catenin signaling pathway, which is important in cancer cell biology (Lager2021Cell). Overexpression of DCD leads to increased β-catenin protein levels and transcriptional activity, which are further enhanced by Wnt signaling activation. This effect is dependent on the function of both GRP78 and DCD, as inhibitory antibodies can abrogate the effect (Lager2021Cell).

DCD also modulates the ERBB signaling pathways in breast cancer. Overexpression of DCD in MCF-7 breast cancer cells results in increased expression of ERBB family receptors and ligands, enhancing cell proliferation and survival. DCD may bind to membrane receptors, promoting EGFR phosphorylation and activation of MAPK and Akt pathways (Bancovik2015Dermcidin). These interactions suggest that DCD plays a role in promoting oncogenic signaling and may contribute to drug resistance in breast cancer (Bancovik2015Dermcidin).


## References


[1. (Tricarico2022A) Paola Maura Tricarico, Rossella Gratton, Carlos André dos Santos-Silva, Ronald Rodrigues de Moura, Blendi Ura, Eduardo Sommella, Pietro Campiglia, Cecilia Del Vecchio, Chiara Moltrasio, Irene Berti, Adamo Pio D’Adamo, Ahmed M. A. Elsherbini, Lena Staudenmaier, Karin Chersi, Michele Boniotto, Bernhard Krismer, Birgit Schittek, and Sergio Crovella. A rare loss-of-function genetic mutation suggest a role of dermcidin deficiency in hidradenitis suppurativa pathogenesis. Frontiers in Immunology, December 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.1060547, doi:10.3389/fimmu.2022.1060547. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.1060547)

[2. (Bancovik2015Dermcidin) Jasna Bancovik, Dayson F Moreira, Daniel Carrasco, Jun Yao, Dale Porter, Ricardo Moura, Anamaria Camargo, Cibely C Fontes-Oliveira, Miguel G Malpartida, Silvia Carambula, Edouard Vannier, Bryan E Strauss, Alda Wakamatsu, Venancio AF Alves, Angela F Logullo, Fernando A Soares, Kornelia Polyak, and José E Belizário. Dermcidin exerts its oncogenic effects in breast cancer via modulation of erbb signaling. BMC Cancer, February 2015. URL: http://dx.doi.org/10.1186/s12885-015-1022-6, doi:10.1186/s12885-015-1022-6. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-015-1022-6)

[3. (Nguyen2017Structural) Van Sang Nguyen, Kang Wei Tan, Karthik Ramesh, Fook Tim Chew, and Yu Keung Mok. Structural basis for the bacterial membrane insertion of dermcidin peptide, dcd-1l. Scientific Reports, October 2017. URL: http://dx.doi.org/10.1038/s41598-017-13600-z, doi:10.1038/s41598-017-13600-z. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-13600-z)

[4. (Lager2021Cell) Tyson W. Lager, Clay Conner, Claudia R. Keating, Jane N. Warshaw, and Athanasia D. Panopoulos. Cell surface grp78 and dermcidin cooperate to regulate breast cancer cell migration through wnt signaling. Oncogene, 40(23):4050–4059, May 2021. URL: http://dx.doi.org/10.1038/s41388-021-01821-6, doi:10.1038/s41388-021-01821-6. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-021-01821-6)

[5. (Jung2010Analysis) Hyun-Ho Jung, Sung-Tae Yang, Ji-Yeong Sim, Seung-Kyu Lee, Ju-Yeon Lee, Ha-Hyung Kim, Song-Yub Shin, and Jae-Il Kim. Analysis of the solution structure of the human antibiotic peptide dermcidin and its interaction with phospholipid vesicles. BMB Reports, 43(5):362–368, May 2010. URL: http://dx.doi.org/10.5483/bmbrep.2010.43.5.362, doi:10.5483/bmbrep.2010.43.5.362. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.5483/bmbrep.2010.43.5.362)